Wednesday, 22 January 2020

Korea News

  • Agilent, Korean Univ study sugars to combat cancer

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 01 Apr, 2013

    Singapore: Agilent Technologies and Korea's Chungnam National University have taken initiatives to further research in glycomics, which is the study of complex sugars, in order to develop b...Read more

  • APAC stem cell therapy market to reach $972mn in 2018

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jan, 2013

    Singapore: A new study by Reports and Reports predicted that the stem cell therapy market in Asia Pacific (APAC) will grow in value from $545 million in 2012 to $972 million in 2018, at a c...Read more

  • Agilent takes steps to empower Korea women

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 30 May, 2014

    Singapore: Biotechnology supplier company, Agilent Technologies is taking initiatives to support women scentists in Korea by forming a partnership with the Center for Women in Science, Engi...Read more

  • ImmunoReagents appoints new distributors in Korea, India

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 15 Oct, 2012

    Singapore: ImmunoReagents, a manufacturer of high quality polyclonal antibodies used by researchers, pharmaceutical and biotechnology companies, has appointed Sungwoo Life Sciences as its n...Read more

  • Bayer recognizes innovation by Korean start-up

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2016

    Singapore: Vital Smith, a Korean startup which focuses on developing innovative technology for diagnostics devices is recognized and acknowledged by Bayer as the final winners of its Grant...Read more

  • Combating infectious diseases with innovative weapons

    Korea |  Opinion | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2012

    The vision at CrystalGenomics is to discover and develop truly novel therapeutics in different disease areas where there are high unmet medical needs. One of these focus areas is infect...Read more

  • Aquavit, Green Cross sign MoU

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2012

    Singapore: Green Cross, a leading biotechnology company in South Korea, has signed a memorandum of understanding (MOU) with US-based Aquavit Pharmaceuticals for strategic collaboration sur...Read more

  • Shinogi starts supply of Pirespa to Ildong

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2012

    Singapore: Osaka-based Shionogi has began to supply Pirespa 200mg tablet (pirfenidone) to Ildong Pharmaceutical, which is headquartered in Seoul, for the treatment of idiopathic pulmonary f...Read more

  • Quest signs $2mn development deal with Korean firm

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

    Singapore: Quest PharmaTech, a pharmaceutical company developing and commercializing products for the treatment of cancer, entered into a long term strategic relationship with AD Biotech, a...Read more

  • Baraclude tops Korea pharma products list

    Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Korea, whose pharma market is being fueled by an aging population with a rising demand for drugs, made it to the top three markets in Asia. China has the biggest market share, while Austral...Read more

  • Top 20 APAC Country Analysis: Korea

    Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 20 Jun, 2015

    Singapore: South Korea is the fourth largest contributor to the lifescience market in the region. • Korean Ministry of Food and Drug Safety (MFDS) stated that medicine exports of th...Read more

  • Novotech to support drug development in Korea

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2014

    Singapore: Australian clinical research organization, Novotech, has partnered with Korea Drug Development Fund (KDDF) to promote development of Korean biotechnology sector in the Asia Pacif...Read more

  • Samsung Bioepis, Merck in biosimilars deal

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

    Singapore: Seoul-based Samsung Bioepis and MSD, known as Merck in the US and Canada, have entered into an agreement to develop and commercialize multiple pre-specified and undisclosed biosi...Read more

  • What bioscience trends do the industry leaders predict for 2013?

    Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2013

    The bioscience industry is about to step into 2013 and the year is predicted to unfold with new opportunities and trends that were so far just talk in the laboratories. First and foremost, ...Read more

  • What are the key mergers & acquisitions of Q1 2013?

    Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The big players of the industry are thus looking for mergers & acqui...Read more

  • Cancer claimed 8.2 mn lives in 2012: UN

    Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2014

    Singapore: Cancer is the biggest cause of mortality worldwide as the killer disease claimed an estimated 8.2 million lives in 2012 and the number of cases is set to rise by 75 percent in co...Read more

  • Celltrion launches Remisma in 12 EU countries

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 25 Feb, 2015

    Singapore: Celltrion Healthcare has announced the launch of Remisma (infliximab) in 12 European markets, namely, Austria, Belgium, Denmark, France, Germany, Greece, Italy, Luxembourg, the N...Read more

  • Will the next blockbuster emerge from Asia?

    Korea |  Opinion | By Nandita Singh | 0 Comment | 17 Oct, 2012

    Blockbusters and super profits. Will the bioscience industry in this decade see these words come to life? More importantly, will these new examples emerge from companies in Asia? Two years...Read more



Podcast

 

Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls